Higher High-Mobility Group Box-1 Levels are Associated with White Matter Lesions in Ischemic Stroke Patients
Jie Zhao,Fang Xu,Wanying Xu,Rong Lv,Juan Wang,Xufeng Yang
DOI: https://doi.org/10.2147/jir.s432109
IF: 4.5
2023-10-10
Journal of Inflammation Research
Abstract:Jie Zhao, 1 Fang Xu, 2 Wanying Xu, 1 Rong Lv, 1 Juan Wang, 3 Xufeng Yang 1 1 Department of Geriatrics, Suzhou Ninth People's Hospital, Soochow University, Suzhou, Jiangsu, 215200, People's Republic of China; 2 Department of Obstetrics and Gynecology, Suzhou Wujiang District Hospital of Traditional Chinese Medicine, Suzhou, Jiangsu, 215200, People's Republic of China; 3 Department of Endocrine, Suzhou Ninth People's Hospital, Soochow University, Suzhou, Jiangsu, 215200, People's Republic of China Correspondence: Xufeng Yang, Department of Geriatrics, Suzhou Ninth People's Hospital, Soochow University, No. 2666 Ludang Road, Suzhou, Jiangsu, 215200, People's Republic of China, Tel/Fax +86 0512-82881332, Email Background and Purpose: High-mobility group box-1 (HMGB1) is a useful biomarker for disease severity stratification and prognosis prediction. We aim to explore whether the circulating HMGB1 concentrations are associated with the white matter lesions (WMLs) burden in stroke patients. Methods: Between 2022 June and December 2022, patients with acute ischemic stroke were prospectively enrolled. HMGB1 levels were measured by an enzyme-linked immunosorbent assay after admission for all patients. The WMLs severity was assessed by the Fazekas scale. We dichotomized patients into those with moderate–severe WMLs (Fazekas score 3– 6) versus those with none–mild WMLs (Fazekas score 0– 2). Furthermore, based on the severity of periventricular WMLs (PWMLs) and deep WMLs (DWMLs), patients were categorized as none–mild (Fazekas score 0– 1) or moderate–severe (Fazekas score 2– 3). Results: A total of 287 participants (mean age: 64.9 years; 157 male) were analyzed. The median serum HMGB1 levels were 7.3 ng/mL (interquartile, 4.3 ng/mL– 12.3 ng/mL). After adjustment for potential confounders, elevated HMGB1 levels were associated with the presence of moderate–severe WMLs (first quartile vs fourth quartile, odds ratio [OR], 4.101; 95% confidence interval [CI], 1.948– 8.633; P = 0.001) and moderate–severe PWMLs (first quartile vs fourth quartile, OR, 9.181; 95% CI, 4.078– 20.671; P = 0.001). Similar results were found when the HMGB1 levels were analyzed as a continuous variable. Conclusion: This study demonstrated that increased HMGB1 levels were associated with the severity of WMLs, mainly in the periventricular region. Keywords: ischemic stroke, high-mobility-group box 1, white matter lesions, inflammation White matter lesions (WMLs), also known as leukoaraiosis, are frequently detected by magnetic resonance imaging in elderly individuals. 1–3 As one of the neuroimaging features of chronic cerebral small vessel disease, 4 WMLs have a substantial clinical impact through associations with an increased risk of ischemic and hemorrhagic stroke, cognitive impairment, and depression. 5–7 Moreover, it may adversely affect the final functional outcome after ischemic stroke. 8,9 Although age and vascular risk factors are widely considered as major contributors to WMLs, they appear inadequate to fully explain the pathogenesis of WMLs. Therefore, early diagnosis and determining the mechanism of WMLs are important for the functional recovery of stroke patients. As a 30-kDa nuclear and cytosolic ubiquitous protein, HMGB1 (high-mobility group box-1) plays an important role in inflammatory and immune responses to proinflammatory activity. 10–12 Under ischemic conditions, HMGB1 is actively secreted by stimulated inflammatory cells. 13 In the experimental model of middle cerebral artery occlusion, extracellularly secreted HMGB1 induced an inflammatory response via blood–brain barrier disruption. 14 Recently, a prospective study reported that elevated serum HMGB1 levels at admission independently predict poor functional outcome at 1 year. 15 Nevertheless, the relationship between serum HMGB1 and WMLs burden in ischemic stroke patients remains unknown. Interestingly, HMGB1 may mediate white matter injury following traumatic brain injury. 16 We therefore hypothesized that increased HMGB1 levels may be linked to the severity of WMLs. Thus, the aim of this study was to examine whether the circulating HMGB1 levels were associated with the severity of WMLs in patients with ischemic stroke. Additionally, we explore the associations of HMGB1 with WMLs burden in different regions. Between 2022 June and December 2022, patients with first-ever ischemic stroke were prospectively enrolled from Suzhou Ninth People's Hospital. The diagnosis of ischemic stroke was based on a definition from World Health Organization and confirmed by brain computed tomography and/or magnetic re -Abstract Truncated-
immunology